...
首页> 外文期刊>OncoTargets and therapy >Targeting of GIT1 by miR-149* in breast cancer suppresses cell proliferation and metastasis in vitro and tumor growth in vivo
【24h】

Targeting of GIT1 by miR-149* in breast cancer suppresses cell proliferation and metastasis in vitro and tumor growth in vivo

机译:miR-149 *在乳腺癌中靶向GIT1可抑制体外细胞增殖和转移以及体内肿瘤的生长

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Breast cancer remains a major cause of cancer-related death in women worldwide. Dysregulation of microRNAs (miRNAs) is involved in the initiation and progression of breast cancer. Moreover, it was found that GIT1 was widely involved in the development of many human cancers. Herein, we aimed to investigate the expression changes of miR-149* and GIT1 and the functional effects of miR-149*/GIT1 link in breast cancer. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and Western blot (WB) were used to examine the expression levels of miR-149* and GIT1. Dual luciferase reporter assay was utilized to confirm the target interaction between miR-149* and GIT1. The biological functions, including cell proliferation, invasion, and migration, of miR-149* and GIT1 were determined by MTT assay and Transwell assays, respectively. Eventually, the tumor xenograft model in nude mice injected with stable transfected MDA-MB-231 cells was established to verify the effects of miR-149* and GIT1 on tumor growth. Our results showed that miR-149* expression was decreased, whereas GIT1 expression was increased in clinical samples of breast cancer. Based on the inverse expression trend between miR-149* and GIT1, we further demonstrated that miR-149* indeed directly targets GIT1. Subsequently, it was observed that inhibition of miR-149* significantly promoted cell proliferation, invasion, and migration, but the ability of cell proliferation, invasion, and migration was obviously declined after silencing of GIT1 in MDA-MB-231 cells transfected with miR-149* mimic and/or si-GIT1. Finally, it was also found that elevated miR-149* decelerated the tumor growth, while restored GIT1 accelerated the tumor growth in nude mice after 35?days of tumor xenograft. Collectively, these findings concluded that miR-149* might exert a tumor suppressive role in breast cancer by targeting GIT1.
机译:乳腺癌仍然是全世界女性与癌症相关的死亡的主要原因。 microRNA(miRNA)的失调与乳腺癌的发生和发展有关。此外,发现GIT1广泛参与许多人类癌症的发展。在本文中,我们旨在研究miR-149 *和GIT1的表达变化以及miR-149 * / GIT1链接在乳腺癌中的作用。定量逆转录-聚合酶链反应(qRT-PCR)和蛋白质印迹(WB)用于检查miR-149 *和GIT1的表达水平。利用双重荧光素酶报告基因测定法来确认miR-149 *与GIT1之间的靶标相互作用。 miR-149 *和GIT1的生物学功能(包括细胞增殖,侵袭和迁移)分别通过MTT分析和Transwell分析确定。最终,建立了用稳定转染的MDA-MB-231细胞注射的裸鼠的肿瘤异种移植模型,以验证miR-149 *和GIT1对肿瘤生长的影响。我们的结果表明,在乳腺癌的临床样本中,miR-149 *表达降低,而GIT1表达升高。基于miR-149 *和GIT1之间的反向表达趋势,我们进一步证明了miR-149 *实际上直接靶向GIT1。随后,观察到抑制miR-149 *显着促进了细胞增殖,侵袭和迁移,但是在miR转染的MDA-MB-231细胞中,GIT1沉默后,细胞增殖,侵袭和迁移的能力明显下降。 -149 *模拟和/或si-GIT1。最后,还发现在异种移植35天后,升高的miR-149 *会减慢肿瘤的生长,而恢复的GIT1则促进裸鼠的肿瘤生长。这些发现共同得出结论,miR-149 *可能通过靶向GIT1在乳腺癌中发挥抑癌作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号